Tempest Therapeutics (TPST – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where chronic viral hepatitis and liver diseases contribute to its high ...

It offers a non-invasive approach and has broad clinical relevance in cancer management. This comprehensive review primarily ...

Hua Zhuang; Yu-lan Peng; Tian-wu Chen; Yong Jiang; Yan Luo; Qiong Zhang; Zhi-gang Yang ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced ...

Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...

Hepatocellular carcinoma (HCC) is a significant global health concern, particularly in regions like the Asia-Pacific, where ...

The summit, known for its pivotal discussions on advancements in cancer treatment, commenced with a focus on Hepatocellular ...

We aimed to investigate the influence of sex disparities on the proliferation and accumulation of macrophages, one of the major components of the tumor microenvironment, in hepatocellular carcinoma ...

Lenvatinib plus pembrolizumab has improved survival rates for patients with intermediate-stage hepatocellular cancer, ...

Received a "Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) to evaluate amezalpat in combination ...